Evidence map›Paper›PMID 40547235›Full record

ArticleWorld journal of orthopedics2025

Validation of "Victorian institute of sports assessment for patellar tendons" in patellofemoral pain: Reliability, interpretability and feasibility study.

Gema Chamorro-Moriana, Fernando Espuny-Ruiz, Carmen Ridao-Fernandez, Eleonora Magni

Abstract read
In one paragraph

Article in World journal of orthopedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gema Chamorro-MorianaDepartment of Physiotherapy, University of Seville, Sevilla 41009, Andalusia, Spain.
Fernando Espuny-RuizDepartment of Physiotherapy, University of Seville, Sevilla 41009, Andalusia, Spain.
Carmen Ridao-FernandezDepartment of Physiotherapy, University of Seville, Sevilla 41009, Andalusia, Spain. mridao@us.es.
Eleonora MagniDepartment of Nursing, University of Seville, Sevilla 41009, Andalusia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Victorian institute of sports assessment for patellar tendons questionnaire (VISA-P), a valid tool for patellar tendinopathy, has been used for patellofemoral pain (PFP).

aimTo validate VISA-P in PFP.

methodsStudy of validity, responsiveness and feasibility following COSMIN. Inclusion criteria: Subjects with PFP, aged 18 to 55. Agreement among 10 experts on the relevance and clarity of each item using Aiken's V coefficient determined content validity. An exploratory factorial analysis established structural validity. The correlation of VISA-P with knee injury and osteoarthritis outcome score for PFP and Osteoarthritis (KOOS-PF) and Kujala patellofemoral score (KPS; specific for PFP) analyzed the construct validity. Internal consistency was calculated with Cronbach's

resultsThe sample consisted of 103 knees from 73 subjects (47 female/26 male; aged 34.9 ± 13 SD). The items were relevant and clear, with the exception of item-8, which didn't reach an acceptable level of agreement on clarity. Exploratory factorial analysis found a 2-factor solution, which explained 63.48% of the variance. VISA-P achieved a strong and significant correlation with KOOS-PF (Spearman rho = 0.826;

conclusionVISA-P proved to be valid and reliable to functionally assess PFP and/or chondromalacia patella. VISA-P is a feasible tool in the clinical and research environment, quick and easy to complete.

Indexed as

Outcome measuresPatellar chondromalaciaPatellofemoral painReliabilityValidity

Identifiers

PMID40547235
PMCPMC12179896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.